What Is the First-Line Treatment of Overt Hepatic Encephalopathy?
Clinical Scenario
Overt hepatic encephalopathy (OHE) is a neuropsychiatric complication of liver disease that requires prompt, structured intervention. First-line management follows a defined sequence: rapid identification of the episode trigger, a targeted pharmacological intervention, and immediate nutritional support — all initiated together.
Treatment Approach (Partial Overview)
The cornerstone of initial management is identifying and correcting the precipitating factor — which may include infection, gastrointestinal bleeding, electrolyte disturbance, or constipation. Correction of the precipitating cause alone resolves the majority of episodes. Alongside this, a specific first-line pharmacological agent — a laxative therapy — is titrated to a defined stool-frequency endpoint. Structured nutritional therapy is started without delay, addressing both energy and protein requirements.
The full protocol — including the complete treatment algorithm, specific agents, titration guidance, and nutritional targets — is available in the structured evidence-based regimen.
Treatment target: achieve at least two soft or loose bowel movements per day, then maintain two to three bowel movements per day.
References
DOI: 10.1002/hep.27210
- Identify and treat precipitating factors for HE (GRADE II-2, A, 1).
- Controlling precipitating factors in the management of OHE is of paramount importance, because nearly 90% of patients can be treated with just correction of the precipitating factor.
- Lactulose is the first choice for treatment of episodic overt hepatic encephalopathy (OHE) (GRADE II-1, B, 1).
- Daily energy intakes should be 35-40 kcal/kg ideal body weight (GRADE I, A, 1).
- Daily protein intake should be 1.2-1.5 g/kg/day (GRADE I, A, 1).
- Small meals or liquid nutritional supplements evenly distributed throughout the day and a late-night snack should be offered (GRADE I, A, 1).
View source ↗